It is widely accepted that immunoglobulin (Ig)E triggers immediate hypersensitivity responses by activating a cognate high-affinity receptor, Fc ⑀ RI, leading to mast cell degranulation with release of vasoactive and proinflammatory mediators. This apparent specificity, however, is complicated by the ability of IgE to bind with low affinity to Fc receptors for IgG, Fc ␥ RII and III. We have addressed the in vivo significance of this interaction by studying IgE-mediated passive systemic anaphylaxis in Fc ␥ R-deficient mice. Mice deficient in the inhibitory receptor for IgG, Fc ␥ RIIB, display enhanced IgE-mediated anaphylactic responses, whereas mice deficient in an IgG activation receptor, Fc ␥ RIII, display a corresponding attenuation of IgE-mediated responses. Thus, in addition to modulating IgG-triggered hypersensitivity responses, Fc ␥ RII and III on mast cells are potent regulators of IgE-mediated responses and reveal the existence of a regulatory pathway for IgE triggering of effector cells through IgG Fc receptors that could contribute to the etiology of the atopic response.
T he anaphylaxis reaction in mice has been considered to be a typical immediate hypersensitivity response determined primarily by the activation of mast cells via antigeninduced aggregation of an IgE-sensitized high-affinity receptor for IgE (Fc ⑀ RI), 1 causing the release of potent systemic mediators (1, 2) . The central role of Fc ⑀ RI in mediating the response was demonstrated by observations that mice deficient in this receptor fail to undergo IgE-dependent, passive cutaneous (3) and passive systemic anaphylaxis (4) . These results were interpreted as indicating a necessary and sufficient role for Fc ⑀ RI in mediating the IgE-dependent anaphylactic response, excluding the possibility for involvement of other potential receptors for IgE (5) . However, earlier observations indicated that the low-affinity Fc receptors for IgG (Fc ␥ RIIB and Fc ␥ RIII) on mouse mast cells, macrophages, and the rat mucosal type mast cell RBL-2H3 can bind IgE immune complexes in vitro (6, 7) , and the engagement of Fc ␥ RIIB/III with IgE immune complexes triggers C57.1 mast cells to release serotonin (6) , suggesting a greater potential complexity to the IgE-mediated anaphylactic response.
Studies on active anaphylaxis in gene-targeted mice further challenged the simple model of IgE and Fc ⑀ RI as the sole initiators of anaphylaxis and revealed a critical role for IgG and Fc ␥ R in this response. Induction of active anaphylaxis in mice deficient in IgE indicated that IgE antibodies were not essential for the expression of systemic anaphylaxis (8) . In addition, mice deficient in Fc ⑀ RI mounted an undiminished active systemic anaphylactic response, whereas active sensitization and challenge of animals deficient in the common ␥ chain (FcR ␥ Ϫ / Ϫ ) resulted in protection (9, 10) . Further support for the conclusion that type I immediate hypersensitivity has a significant dependence on IgG1 and Fc ␥ Rs came from studies demonstrating that Fc ␥ RIIBdeficient (Fc ␥ RIIB Ϫ / Ϫ ) mice exhibited an enhanced reaction in IgG1-mediated passive cutaneous anaphylaxis, thereby
Regulation of IgE-mediated Anaphylaxis by Fc ␥ Receptors establishing the importance of Fc ␥ RIIB as an inhibitory receptor under physiologic conditions (11) , as suggested previously in extensive in vitro studies by Daëron and colleagues (12, 13; for review see reference 14) .
Although the evidence supporting a direct role for IgG and Fc ␥ Rs in the anaphylaxis reaction is compelling, the contribution of these receptors to the canonical IgE-mediated response is generally considered to be minimal. To directly analyze the roles of Fc ␥ RIIB and Fc ␥ RIII in the IgE-dependent component of the systemic anaphylaxis reaction, we compared the responses elicited in Fc ␥ RIIB Ϫ / Ϫ and Fc ␥ RIII Ϫ / Ϫ mice upon passive transfer of either anti-TNP IgE or IgG followed by intravenous challenge with TNP-OVA. As expected, Fc ␥ RIIB Ϫ / Ϫ and Fc ␥ RIII Ϫ / Ϫ mice displayed enhanced or attenuated systemic anaphylaxis to IgG1 sensitization, respectively. However, contrary to the accepted dogma, intense modulation of IgE-dependent systemic anaphylaxis was also observed in these Fc ␥ R Ϫ / Ϫ mice as a result of the low-affinity interactions of IgE-antigen complexes with these receptors. These studies demonstrate the in vivo physiological significance of low-affinity IgE interactions with Fc ␥ Rs and represent a novel regulatory pathway for classical type I hypersensitivity responses.
Materials and Methods
Antibodies. Rat anti-mouse Fc ␥ RIIB/III (2.4G2; PharMingen) and mouse anti-TNP IgE (IGELa2; American Type Culture Collection) and anti-TNP IgG1 (G1; 15) were purified from the ascites of hybridomas by ion exchange chromatography on DEAEcellulose (Merck) (16) and by affinity isolation with protein G column (17) , followed by removal of aggregated materials by ultracentrifugation at 130,000 g for 90 min at 20 Њ C.
Animals. All experiments were performed on 6-12-wk-old mice. Male and female Fc ␥ RIIB Ϫ / Ϫ (11) or Fc ␥ RIII Ϫ / Ϫ mice (Y. Ishikawa, J.V. Ravetch, and T. Takai, unpublished results) were generated by breeding the F2 offspring of crosses between chimeras and C57BL/6 mice, and the wild-type mice generated by the same breeding protocol were used as wild-type animals. Fc ␥ R Ϫ / Ϫ mice were generated as described previously (3) and back-crossed to C57BL/6 background over six generations. Fc ␥ RIII Ϫ / Ϫ mice were generated using RW4 embryonic stem cells (GenomeSystems Inc.) as described previously (3, 11) . Mice were housed in cages in cabinets supplied with high efficiency particulate-free air and were monitored monthly as specific pathogen free.
Induction of Passive Systemic Anaphylaxis. Mouse IgG1 or IgE anti-TNP mAbs were administered intravenously through the tail vein in volumes of ‫ف‬ 200 l/mouse. 30 min after injection of anti-TNP IgG1 or 24 h after injection of IgE, mice were injected with 1.0 mg i.v. TNP 4 -OVA in PBS. Control mice received OVA in PBS instead. The concentration of IgG1 and IgE mAbs used for passive sensitization and the amount of TNP-OVA used for challenge was determined based on preliminary dose-response experiments required to produce significant drops in body temperature in wild-type and Fc ␥ RIIB Ϫ / Ϫ or Fc ␥ RIII Ϫ / Ϫ mice. Alternatively, systemic anaphylaxis was induced by the intravenous injection of 10 g 2.4G2 in 200 l PBS. The amount was determined based on the preliminary dose-response experiment in the same way described above. In a blocking experiment in Fc ␥ RIII Ϫ / Ϫ mice, 100 g 2.4G2 was administered.
Monitoring of Rectal Temperature and Heart Rate. Changes in core body temperature associated with systemic anaphylaxis were monitored by measuring changes in rectal temperature using a rectal probe coupled to a digital thermometer (Natsume Seisakusyo Co.) as described (4, 9, 10) . Heart rate was recorded as electrocardiograms (Nihon Kohden) of mice under 2,2,2-tribromoethanol (0.25 mg/g body weight, i.p.) anesthesia.
Flow Cytometric Analysis. Bone marrow-derived cultured mast cells (BMMC) were prepared as described previously (3) . For monitoring of upregulation of Fc ⑀ RI protein on BMMC membrane, cells were cultured in the presence of 0.1 or 5 g/ml biotinylated IgE or 5 g/ml biotinylated 2.4G2 for 4 d before final staining with biotinylated IgE (5 g/ml) plus PE-conjugated streptavidin. Peritoneal resident cells were collected by washing with Tyrode's buffered solution and incubated with 5 g/ml IgE for 20 min at 4 Њ C to saturate IgE binding to Fc ⑀ RI, followed by staining with FITC-conjugated rat anti-mouse IgE (Serotec Ltd.) for 20 min at 4 Њ C. Flow cytometric analyses were performed with FACSCalibur™ (Becton Dickinson), and peritoneal mast cells were sorted as c-kit and IgE-positive cells as described (18) .
ELISA Determinations for Blood Histamine. Blood was collected from subocular plexus of mice into microcentrifuge tubes containing EDTA on ice at 5 min after antigen challenge, and plasma was prepared. Histamine in the plasma samples was quantified using ELISA plates (ICN Pharmaceuticals, Inc.) according to the manufacturer's instructions.
Histological Study. Mice were killed by cervical dislocation. Their tissues were removed and fixed in 10% (vol/vol) neutral buffered formalin and then embedded in paraffin. The specimens were sectioned at 3 m and stained with toluidine blue at pH 4.0. The number of mast cells/mm 2 was determined under a light microscope. A 'degranulated' mast cell was defined as a cell showing extrusion of Ͼ 10% cell granules.
Statistical Analysis. Statistical differences were calculated using Student's t test or Fisher's test. P Ͻ 0.05 was considered significant.
Results and Discussion
Modulation of IgG1-mediated Systemic Anaphylaxis in Fc␥RIIB Ϫ/Ϫ or Fc␥RIII Ϫ/Ϫ Mice. Bocek et al. (7) reported that coclustering of Fc␥RIIB and Fc␥RIII on RBL-2H3 cells did not lead to stimulation of the cells, suggesting a possible inhibitory role of Fc␥RIIB in this process. In addition, in vitro observations by Daëron et al. (12) demonstrated that mast cell secretory responses triggered by Fc⑀RI may be controlled by Fc␥RIIB/III. Moreover, the regulatory role of Fc␥RIIB was also observed in the cellular activation process via B cell receptors (19) (20) (21) and T cell receptors (13; for review see reference 14). Our previous studies using gene-targeted mice had demonstrated the role of Fc␥RIIB in modulating IgG1-mediated passive cutaneous anaphylaxis (11) . To establish the generality of those in vivo observations, we investigated IgG1-mediated passive systemic anaphylaxis in Fc␥RIIB Ϫ/Ϫ and Fc␥RIII Ϫ/Ϫ mice. We chose to evaluate a passive rather than active model in our studies because Fc␥RIIB Ϫ/Ϫ mice display enhanced humoral immune responses (11) that could complicate the comparison and interpretation of the anaphylactic responses. To elicit the anaphylactic response, mice were injected intravenously with IgG1 specific for TNP, followed by intravenous administration of TNP-OVA 30 min later. Fig. 1 A shows that Fc␥RIIB Ϫ/Ϫ mice developed an enhanced IgG1-dependent passive systemic anaphylactic response as compared with passively sensitized wild-type controls challenged with TNP-OVA. In wild-type mice, the decrease in core temperature was also transient, reaching a nadir ‫51ف‬ min after induction, whereas the drop in temperature of Fc␥RIIB Ϫ/Ϫ mice persisted for more than 30 min without returning to baseline.
The mAb 2.4G2 is specific for the extracellular domains of murine Fc␥RIIB and Fc␥RIII (22) . 2.4G2 induces a degranulative response in BMMC, which is enhanced in cells derived from Fc␥RIIB Ϫ/Ϫ mice (11). This enhancement is apparent in vivo as well as shown in Fig. 1 B, where the decrease in core temperature after administration of 2.4G2 was more pronounced in Fc␥RIIB Ϫ/Ϫ mice than in control mice. These results indicate that Fc␥RIIB on effector cells, such as mast cells, inhibits the systemic anaphylaxis elicited via Fc␥RIII. In contrast to the enhanced responses in Fc␥RIIB Ϫ/Ϫ mice described above (Fig. 1, A and B) , both Fc␥RIII Ϫ/Ϫ mice and FcR␥ Ϫ/Ϫ mice failed to develop IgG1-mediated passive systemic anaphylaxis (Fig. 1 C) , directly establishing that IgG1-mediated anaphylaxis is triggered through Fc␥RIII, as was indirectly suggested by others (9, 10) .
Enhancement of IgE-mediated Anaphylaxis in Fc␥RIIB Ϫ/Ϫ Mice. As IgE immune complexes can bind with low affinity to Fc␥RII and III in vitro, we next induced passive systemic anaphylaxis upon anti-TNP IgE adoptive transfer and TNP-OVA administration into Fc␥RIIB Ϫ/Ϫ mice. IgE-mediated systemic anaphylaxis was significantly enhanced in Fc␥RIIB Ϫ/Ϫ mice, as assessed by changes in core temperature (Fig. 2 A) , heart rate ( Fig. 2 B) , and augmented hemorrhage in the ileum villi (Fig. 2 C) . These results indicate that IgE/Fc⑀RI-mediated anaphylaxis is facilitated by the deletion of Fc␥RIIB in vivo without any apparent involvement of IgG-immune complexes.
Systemic anaphylaxis can result in a fatal outcome. In mice, this mortality has been shown to be associated with IgG1 and Fc␥RIII (9) . As shown in Table I , we observed mortality as a consequence of the anaphylactic response only in Fc␥RIIB Ϫ/Ϫ mice upon administration of either IgG1 or IgE and the corresponding antigen, or 2.4G2. These results confirm that either IgE-or IgG-induced systemic anaphylaxis is indeed augmented in Fc␥RIIB Ϫ/Ϫ mice, as assessed by mortality during anaphylaxis.
Neither Fc⑀RI Expression Level nor Mast Cell Density Is
Upregulated in Fc␥RIIB Ϫ/Ϫ Mice. These unexpected observations for IgE-mediated anaphylaxis prompted us to examine whether deletion of Fc␥RIIB influenced Fc⑀RI expression levels on effector cells. We confirmed by flow cytometric analysis that the expression level of Fc⑀RI on BMMC from Fc␥RIIB Ϫ/Ϫ mice was comparable to the level on wildtype BMMC (data not shown). In addition, we could not demonstrate any significant difference in the expression levels of Fc⑀RI on mast cells after IgE-induced upregulation in vitro or in vivo (Fig. 3, A and B) . As shown in Fig.  3 A, BMMC derived from either from Fc␥RIIB Ϫ/Ϫ or wild-type mice displayed the same level of upregulation of Fc⑀RI in response to IgE (18) . Similarly, peritoneal mast cells isolated from Fc␥RIIB Ϫ/Ϫ and wild-type mice 24 h after intravenous administration of 20 g IgE had equivalent levels of Fc⑀RI (Fig. 3 B) . Histopathological examinations indicated that the density and morphology of mast cells in ear, abdominal skin, and trachea from the mutant mice were not significantly different from those in wildtype mice (data not shown).
Increases in the Number of Degranulated Mast Cells and in Blood Histamine Levels after IgE-mediated Anaphylaxis Induction. The mechanism by which Fc␥RIIB Ϫ/Ϫ mice augmented IgE-mediated anaphylaxis was examined by determining the activation of effector cells in these animals as compared with their wild-type counterparts. Blood histamine levels were measured after the induction of anaphylaxis in Fc␥RIIB Ϫ/Ϫ and wild-type mice. As shown in Fig.  4 A, blood obtained both from wild-type or Fc␥RIIB Ϫ/Ϫ -sensitized animals 5 min after challenge with antigen or 2.4G2 revealed increased histamine concentrations. The histamine levels seen in Fc␥RIIB Ϫ/Ϫ -challenged mice were consistently higher in response to IgE, IgG1, or 2.4G2 stimulation than in control mice, suggesting that the enhanced anaphylaxis in Fc␥RIIB Ϫ/Ϫ mice could be interpreted in part by accelerated activation of mast cells in the mutant animals. To directly demonstrate enhanced degranulation, lung samples from Fc␥RIIB Ϫ/Ϫ or wild-type mice were removed before and 30 min after the induction of IgG-mediated passive systemic anaphylaxis and examined histopathologically. As shown in Fig. 4 B and E, mast cells around bronchi in Fc␥RIIB Ϫ/Ϫ mice displayed quantitatively more degranulation than comparable samples taken from wild-type mice subjected to similar treatment. (23) . This inositol polyphosphate phosphatase is recruited to Fc␥RIIB upon cross-linking with an immunoreceptor tyrosine-based activation motif (ITAM)-containing activation receptor through its SH2 (Src homology 2) domain and leads to the hydrolysis of phosphatidylinositol 3,4,5-trisphosphate, with release of Bruton's tyrosine kinase and phospholipase C␥ from the inner leaflet of the cell membrane (24) . The net result of this pathway is the termination of calcium influx, with subsequent inhibition of activation responses (20, 21, 25) . Mast cells derived from SHIP-deficient mice display a hyperresponsive IgE phenotype similar to the response seen in Fc␥RIIB Ϫ/Ϫ mice (26) . Thus, functional uncoupling of Fc␥RIIB from its signaling pathway results in similar phenotype deletion of the receptor itself.
Conclusions. Although Takizawa et al. (6) demonstrated that Fc␥RIIB and Fc␥RIII act as low-affinity receptors for
The observations presented here support the hypothesis that IgE-mediated activation is modulated by inhibitory receptors like Fc␥RIIB. Perturbation of an inhibitory pathway would be predicted to render mast cells more sensitive to IgE activation and could account for some atopic phenotypes. Upregulation of Fc␥RIIB or its constitutive engagement would result in desensitization of mast cells to IgE triggering and reversal of the atopic state.
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